Platform
Home
Screener
Copilot
AskEdgar Studio
New
Back
ResMed Inc.
RMD · SEC Filings
website
11.4K
ResMed Inc. is a leading global medical technology enterprise engaged in the creation, production, d...
Price
235.74
Market Cap
33.16 B
Float
139.33 M
Country
US
Sector
Healthcare
Exchange
NYSE
Overview
Filings
Insights
Dilution
News
Transcripts
Search in Documents
Open in Studio
Studio
Login
Ask about RMD
TYPE
HEADLINE
FILED AT
TYPE
HEADLINE
FILED AT
TYPE
HEADLINE
FILED AT
TYPE
HEADLINE
FILED AT
All
Chronological
Financials
Registrations
Prospectus
News
Proxies
Ownerships
Other
ResMed Inc.
RMD · SEC Filings
139.33 M
Float
235.74
Price
33.16 B
Market Cap
Financials
TYPE
HEADLINE
FILED AT
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 29, 2026
10-K
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Aug 13, 2026
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 30, 2026
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jan 29, 2026
10-Q
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 30, 2025
10-K
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Aug 7, 2025
News
TYPE
HEADLINE
FILED AT
8-K
ResMed Announces First Quarter Fiscal Year 2027 Results, Reporting 6% Revenue Growth and $1B Returned to Shareholders
Oct 29, 2026
8-K
ResMed Inc. Enters $450 Million Accelerated Share Repurchase Agreement
Sep 1, 2026
8-K
ResMed Announces Appointment of Carol Burt as Lead Director and Retirement of Ron Taylor
Aug 17, 2026
8-K
ResMed Inc. Announces Results for the Fourth Quarter and Full Fiscal Year 2026
Aug 6, 2026
8-K
ResMed Announces Agreement to Sell MatrixCare Business to Frazier Healthcare Partners
Jul 7, 2026
8-K
ResMed CFO Brett Sandercock to Retire; Aaron Bloomer Appointed as Successor
Apr 30, 2026
Prospectus
TYPE
HEADLINE
FILED AT
424B3
UP TO 853,448 SHARES OF
Mar 27, 2003
424B3
Common Stock Owned Prior to the Offering
Sep 12, 2002
424B3
Registration
May 2, 2002
424B3
Registration
Feb 22, 2002
424B3
Registration
Feb 15, 2002
424B3
Registration
Jan 17, 2002
Registrations
TYPE
HEADLINE
FILED AT
S-8
Form S-8 - Securities to be offered to employees in employee benefit plans
Nov 21, 2025
S-8
Form S-8 - Securities to be offered to employees in employee benefit plans
Nov 21, 2025
S-8
$50,000,000
May 21, 2021
S-8
2,000,000 additional shares of Common Stock issuable under the Plan.
Aug 13, 2020
S-8
Registration
Apr 30, 2018
S-8
Registration
Feb 28, 2014
Proxies
TYPE
HEADLINE
FILED AT
DEFA14A
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Oct 1, 2026
DEF 14A
Form DEF 14A - Other definitive proxy statements
Oct 1, 2026
DEFA14A
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Oct 2, 2025
DEF 14A
Form DEF 14A - Other definitive proxy statements
Oct 2, 2025
DEFA14A
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Oct 25, 2024
DEFA14A
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Oct 3, 2024
Ownerships
TYPE
HEADLINE
FILED AT
144
NEW
Form 144 - Report of proposed sale of securities
Nov 9, 2026
4
Rider Michael J (Reporting)
Oct 26, 2026
144
Form 144 - Report of proposed sale of securities
Oct 23, 2026
4
Farrell Michael J. (Reporting)
Oct 8, 2026
144
Form 144 - Report of proposed sale of securities
Oct 7, 2026
4/A
Farrell Michael J. (Reporting)
Oct 1, 2026
Chronological
TYPE
HEADLINE
FILED AT
Other
TYPE
HEADLINE
FILED AT
SD
Form SD - Specialized disclosure report
May 26, 2026
SD
Form SD - Specialized disclosure report
May 29, 2025
SD
Form SD - Specialized disclosure report
May 30, 2024
SD
Form SD - Specialized disclosure report
May 26, 2023
SD
Form SD - Specialized disclosure report
May 26, 2022
SD
Form SD - Specialized disclosure report
May 26, 2021
